Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_assertion description "[Imatinib is effective in patients with increased mast cells and eosinophils associated with FIP1L1/PDGFRA+ (e.g., myeloid neoplasm with eosinophilia and rearrangement of PDGFRA) or rare patients with SM associated with KIT mutations outside of exon 17.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_assertion evidence source_evidence_literature NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_assertion SIO_000772 21641642 NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_assertion wasDerivedFrom befree-20150227 NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_assertion wasGeneratedBy ECO_0000203 NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP613961.RABXV_jj_Qb6H7AbOrud5wyMoo4Hhfxdn6iIbpMLQrIqw130_provenance.